EUVIMEDEUVIMED entdecken
Open Access

Real-time imaging of drug-induced trapping of cellular topoisomerases and poly(ADP-ribose) polymerase 1 at the single-molecule level

Yilun Sun iD, Jiji Chen, Yves Pommier iD

Nucleic Acids Research · 2023

DOI: 10.1093/nar/gkad735 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2023. Verfasst von Yilun Sun und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Pharmacology and Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institute…. Hauptthemen laut MEDLINE: Poly(ADP-ribose) Polymerase Inhibitors, Poly(ADP-ribose) Polymerases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Topoisomerases (TOP1, TOP2α, and β) are nuclear enzymes crucial for virtually all aspects of DNA metabolisms. They also are the targets of important anti-tumor chemotherapeutics that act by trapping the otherwise reversible topoisomerase-DNA covalent complex intermediates (TOPccs) that are formed during their catalytic reactions, resulting in long-lived topoisomerase DNA-protein crosslinks (TOP-DPCs) that interfere with DNA transactions. The Poly(ADP-ribose) polymerase (PARP) family protein PARP1 is activated by DNA damage to recruit DNA repair proteins, and PARP inhibitors are another class of commonly used chemotherapeutics, which bind and trap PARP molecules on DNA. To date, the trapping of TOPccs and PARP by their respective inhibitors can only be measured by immune-biochemical methods in cells. Here, we developed an imaging-based approach enabling real-time monitoring of drug-induced trapping of TOPccs and PARP1 in live cells at the single-molecule level. Capitalizing on this approach, we calculated the fraction of self-fluorescence tag-labeled topoisomerases and PARP single-molecules that are trapped by their respective inhibitors in real time. This novel technique should help elucidate the molecular processes that repair TOPcc and PARP trapping and facilitate the development of novel topoisomerase and PARP inhibitor-based therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Poly(ADP-ribose) Polymerase InhibitorsPoly(ADP-ribose) PolymerasesPoly (ADP-Ribose) Polymerase-1DNA DamageDNA RepairIsomerasesDNA Topoisomerases, Type IDNA

Substanzen

Poly(ADP-ribose) Polymerase InhibitorsPoly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) PolymerasesIsomerasesDNA Topoisomerases, Type IDNA

Autor:innen und Institutionen

  • Laboratory of Molecular Pharmacology and Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  • Advanced Imaging and Microscopy (AIM) Resource, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD 20892, USA.

ORCID-Profile: Yilun Sun, Yves Pommier

Förderung

  • Intramural NIH HHS
  • NCI NIH HHS
  • National Cancer Institute
  • National Cancer Institute Center for Cancer Research

Zitieren

APA

Sun, Y., Chen, J., & Pommier, Y. (2023). Real-time imaging of drug-induced trapping of cellular topoisomerases and poly(ADP-ribose) polymerase 1 at the single-molecule level. Nucleic Acids Research. https://doi.org/10.1093/nar/gkad735

Vancouver

Sun Y, Chen J, Pommier Y. Real-time imaging of drug-induced trapping of cellular topoisomerases and poly(ADP-ribose) polymerase 1 at the single-molecule level. Nucleic Acids Research. 2023. doi:10.1093/nar/gkad735

BibTeX
@article{Sun2023,
  author = {Sun, Yilun and Chen, Jiji and Pommier, Yves},
  title = {Real-time imaging of drug-induced trapping of cellular topoisomerases and poly(ADP-ribose) polymerase 1 at the single-molecule level},
  journal = {Nucleic Acids Research},
  year = {2023},
  doi = {10.1093/nar/gkad735}
}
Kostenlos starten →